A previous study has shown that high OVOL2 expression predicts a prolonged RFS in patients with breast cancer and OVOL2 inhibits breast tumor metastasis.[15] We demonstrated that OVOL2 expression is down‐regulated in breast cancer and that patients with high OVOL2 expression show prolonged DFS and OS. Here, OVOL2 is linked to breast cancer.